Skip to main content
Hit enter to search or ESC to close
Close Search
CD3
search
Menu
  • About us
    • Our mission
    • Our way of working
    • Meet the team
    • Investment partners
    • CD3 Labs – Our expertise
  • For Academics & TTOs
    • Partnering with CD3
    • FAQ
  • For Industry & VCs
  • Pipeline
    • Open to licensing
    • Advanced partnered projects
    • Business Deals
  • News & insights
    • News
    • Success stories
    • Publications
  • Contact
  • Join our team
  • search
Category

Finance

Substantial Open Philanthropy funding to prepare against influenza pandemics
Finance

Substantial Open Philanthropy funding to prepare against influenza pandemics

CD3 raises 70.5 Million Euros for its fourth fund
Finance

CD3 raises 70.5 Million Euros for its fourth fund

CD3 closes 60 million euro fund to turn academic research into new medicines
Finance

CD3 closes 60 million euro fund to turn academic research into new medicines

Recent Posts

  • Sue Foden – In Memoriam
  • CD3 announces investment in Enedra Therapeutics to advance drug discovery programmes from its proprietary CASPAROV platform for difficult to treat cancers
  • KU Leuven joins EndLyz Therapeutics’ fight against Parkinson’s disease
  • Assembly of coronavirus particles as a new target for the development of potent antiviral drugs
  • Harrold van Barlingen – In Memoriam

Recent Comments

No comments to show.

CD3

Bio-incubator 2
Gaston Geenslaan 2
3001 Leuven (Heverlee)
Belgium

info@cd3.be
+32 16 85 26 00

Privacy Policy

© 2026 CD3.

  • linkedin
  • phone
  • email
Close Menu
  • About us
    • Our mission
    • Our way of working
    • Meet the team
    • Investment partners
    • CD3 Labs – Our expertise
  • For Academics & TTOs
    • Partnering with CD3
    • FAQ
  • For Industry & VCs
  • Pipeline
    • Open to licensing
    • Advanced partnered projects
    • Business Deals
  • News & insights
    • News
    • Success stories
    • Publications
  • Contact
  • Join our team
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}